Background: [18F]UCB-H was developed as a novel radiotracer with a high affinity for synaptic vesicle protein 2A, the binding site for the antiepileptic levetiracetam. The objectives of this study were to evaluate the radiation dosimetry of [18F]UCB-H in a preclinical trial and to determine the maximum injectable dose according to guidelines for human biomedical research. The radiation dosimetry was derived by organ harvesting and dynamic micro positron emission tomography (PET) imaging in mice, and the results of both methods were compared.

Methods: Twenty-four male C57BL-6 mice were injected with 6.96 ± 0.81 MBq of [18F]UCB-H, and the biodistribution was determined by organ harvesting at 2, 5, 10, 30, 60, and 120 min (n = 4 for each time point). Dynamic microPET imaging was performed on five male C57BL-6 mice after the injection of 9.19 ± 3.40 MBq of [18F]UCB-H. A theoretical dynamic bladder model was applied to simulate urinary excretion. Human radiation dose estimates were derived from animal data using the International Commission on Radiological Protection 103 tissue weighting factors.

Results: Based on organ harvesting, the urinary bladder wall, liver and brain received the highest radiation dose with a resulting effective dose of 1.88E-02 mSv/MBq. Based on dynamic imaging an effective dose of 1.86E-02 mSv/MBq was calculated, with the urinary bladder wall and liver (brain was not in the imaging field of view) receiving the highest radiation.

Conclusions: This first preclinical dosimetry study of [18F]UCB-H showed that the tracer meets the standard criteria for radiation exposure in clinical studies. The dose-limiting organ based on US Food and Drug Administration (FDA) and European guidelines was the urinary bladder wall for FDA and the effective dose for Europe with a maximum injectable single dose of approximately 325 MBq was calculated. Although microPET imaging showed significant deviations from organ harvesting, the Pearson's correlation coefficient between radiation dosimetry derived by either method was 0.9666.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3655042PMC
http://dx.doi.org/10.1186/2191-219X-3-35DOI Listing

Publication Analysis

Top Keywords

radiation dosimetry
16
organ harvesting
16
urinary bladder
12
bladder wall
12
effective dose
12
maximum injectable
8
dosimetry derived
8
male c57bl-6
8
c57bl-6 mice
8
mbq [18f]ucb-h
8

Similar Publications

We present new developments for an ab-initio model of the neutron relative biological effectiveness (RBE) in inducing specific classes of DNA damage. RBE is evaluated as a function of the incident neutron energy and of the depth inside a human-sized reference spherical phantom. The adopted mechanistic approach traces neutron RBE back to its origin, i.

View Article and Find Full Text PDF

A low-dose CT reconstruction method using sub-pixel anisotropic diffusion.

Nan Fang Yi Ke Da Xue Xue Bao

January 2025

School of Mathematics and Computer Science, Gannan Normal University, Ganzhou 341000, China.

Objectives: We present a new low-dose CT reconstruction method using sub-pixel and anisotropic diffusion.

Methods: The sub-pixel intensity values and their second-order differences were obtained using linear interpolation techniques, and the new gradient information was then embedded into an anisotropic diffusion process, which was introduced into a penalty-weighted least squares model to reduce the noise in low-dose CT projection data. The high-quality CT image was finally reconstructed using the classical filtered back-projection (FBP) algorithm from the estimated data.

View Article and Find Full Text PDF

Several exploratory studies have demonstrated the feasibility of cholecystokinin-2 receptor (CCK2R) targeting in patients with medullary thyroid carcinoma (MTC) and other neuroendocrine tumors (NETs). We report the results of a prospective phase I/IIA pilot study (clinicaltrials.gov NCT06155994) conducted at our center with the Ga-labeled peptide analog DOTA-DGlu-Ala-Tyr-Gly-Trp-(N-Me)Nle-Asp-1-Nal-Phe-NH (Ga-DOTA-MGS5).

View Article and Find Full Text PDF

Background: This study aimed to quantify radiation doses during navigational bronchoscopy procedures, comparing them with reported cohorts and evaluating the LungVision (Body Vision Medical Inc.) system's efficacy in dose reduction.

Methods: This retrospective observational study included 52 consecutive navigational bronchoscopy cases, categorized into 4 imaging groups based on the C-arm: Cios Spin (Siemens Healthineers), or OEC 9900 (GE HealthCare); and the 3D tomographic imaging algorithm: Cios Spin's onboard imaging, or LungVision's AI-driven imaging.

View Article and Find Full Text PDF

Eye lens dosimetry: does the direction of rotation (vertical or horizontal) play a role in type testing?

J Radiol Prot

January 2025

Radiation Protection Dosimetry (6.3), Physikalisch-Technische Bundesanstalt, Braunschweig, NDS, GERMANY.

With the International Commission on Radiological Protection (ICRP) lowering the annual dose limit for the eye lens to 20 mSv, precise monitoring of eye lens exposure has become essential. The personal dose equivalent at a depth of 3 mm, Hp(3), is the measurement method for monitoring the dose to the lens of the eye. Traditional dosimetry methods primarily address lateral radiation exposure scenarios, where radiation approaches from the left or right, necessitating the rotation of the phantom during type testing around the vertical axis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!